Table 3.
The demographic and clinical characteristics between ICH and no-ICH patients.
| ICH(n=6) | no-ICH(n=75) | P Value | |
|---|---|---|---|
| Age (mean ±SD) | 63.3±10.8 | 64.7±10.6 | 0.871 |
| Hypertension (n, %) | 5(83.3%) | 59 (79.7%) | 1.0 (Continuity correction) |
| NIHSS at onset (mean ±SD) | 18±4.4 | 17±4.7 | 0.933 |
| Occlusion (anterior/posterior) | 6/0 | 56/19 | 0.161 (Fisher) |
| Stent (n, %) | 2 (28.6) | 16(21.3) | |
| IV rt-PA | 2 (28.6) | 50 (66.7) | 0.232 (Continuity correction) |
| NOP (mean ±SD) | 1.2±0.4 | 1.3±0.6 | 0.522 |
| TOR (min, mean ±SD) | 74±20 | 55±22 | 0.048* |
| TTR (min, mean ±SD) | 220±50 | 279±127 | 0.260 |
ICH, intracranial hemorrhage; sICH, symptomatic intracranial hemorrhage; NIHSS, the National Institute of Health Scale Score; ASPECT, Alberta Stroke Program Early Computed Tomography Score; IV rt-PA, intravenous recombinant tissue plasminogen activator; NOP, the number of passages of Solitaire stent; TOR, time from onset to recanalization TTR, time from treatment to recanalization. * P< 0.05.